scholarly journals Early real-world evidence of persistence on oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a cohort study in UK primary care

BMJ Open ◽  
2016 ◽  
Vol 6 (9) ◽  
pp. e011471 ◽  
Author(s):  
Michelle E Johnson ◽  
Cinira Lefèvre ◽  
Shuk-Li Collings ◽  
David Evans ◽  
Sebastian Kloss ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Primary Care ◽  
Cohort Study ◽  
Real World ◽  
Stroke Prevention ◽  
Oral Anticoagulants ◽  
Real World Evidence

scholarly journals Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation

Stroke ◽  
2017 ◽  
Vol 48 (9) ◽  
pp. 2494-2503 ◽  
Author(s):  
George Ntaios ◽  
Vasileios Papavasileiou ◽  
Konstantinos Makaritsis ◽  
Konstantinos Vemmos ◽  
Patrik Michel ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Real World ◽  
Stroke Prevention ◽  
Vitamin K Antagonists ◽  
Oral Anticoagulants ◽  
Real World Setting

From novel to routine: new oral anticoagulants for stroke prevention in primary care in Ireland

2020 ◽  
Vol 26 (12) ◽  
pp. 1-4
Author(s):  
Ann Kirby ◽  
Aileen Murphy ◽  
Colin Bradley
Keyword(s):  
Atrial Fibrillation ◽  
Primary Care ◽  
Patient Group ◽  
Patient Experience ◽  
Stroke Prevention ◽  
Oral Anticoagulants ◽  
Healthcare Services ◽  
New Oral Anticoagulants ◽  
Prescribing Practice ◽  
New Treatments

New treatments for atrial fibrillation provide promising opportunities to increase the efficiency of healthcare services while optimising the patient experience. However, research shows that current prescribing practice for this patient group is inconsistent and at odds with international guidelines.

Sign in / Sign up

Export Citation Format

Share Document